Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency

被引:18
|
作者
Tucker, Torry A. [1 ]
Jeffers, Ann [1 ]
Boren, Jake [1 ]
Quaid, Brandon [1 ]
Owens, Shuzi [1 ]
Koenig, Kathleen B. [1 ]
Tsukasaki, Yoshikazu [1 ]
Florova, Galina [1 ]
Komissarov, Andrey A. [1 ]
Ikebe, Mitsuo [1 ]
Idell, Steven [1 ]
机构
[1] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, 11937 US HWY 271,Biomed Res Bldg,Lab C-5, Tyler, TX 75708 USA
来源
关键词
Pleural mesothelial cells; Pneumonia; Plasminogen activator inhibitor-1;
D O I
10.1186/s40169-016-0097-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Pleural infection affects about 65,000 patients annually in the US and UK. In this and other forms of pleural injury, mesothelial cells (PMCs) undergo a process called mesothelial (Meso) mesenchymal transition (MT), by which PMCs acquire a profibrogenic phenotype with increased expression of a-smooth muscle actin (a-SMA) and matrix proteins. MesoMT thereby contributes to pleural organization with fibrosis and lung restriction. Current murine empyema models are characterized by early mortality, limiting analysis of the pathogenesis of pleural organization and mechanisms that promote MesoMT after infection. Methods: A new murine empyema model was generated in C57BL/6 J mice by intrapleural delivery of Streptococcus pneumoniae (D39, 3 x 10(7)-5 x 10(9) cfu) to enable use of genetically manipulated animals. CT-scanning and pulmonary function tests were used to characterize the physiologic consequences of organizing empyema. Histology, immunohistochemistry, and immunofluorescence were used to assess pleural injury. ELISA, cytokine array and western analyses were used to assess pleural fluid mediators and markers of MesoMT in primary PMCs. Results: Induction of empyema was done through intranasal or intrapleural delivery of S. pneumoniae. Intranasal delivery impaired lung compliance (p < 0.05) and reduced lung volume (p < 0.05) by 7 days, but failed to reliably induce empyema and was characterized by unacceptable mortality. Intrapleural delivery of S. pneumoniae induced empyema by 24 h with lung restriction and development of pleural fibrosis which persisted for up to 14 days. Markers of MesoMT were increased in the visceral pleura of S. pneumoniae infected mice. KC, IL-17A, MIP-1 beta, MCP-1, PGE(2) and plasmin activity were increased in pleural lavage of infected mice at 7 days. PAI-1(-/-) mice died within 4 days, had increased pleural inflammation and higher PGE2 levels than WT mice. PGE2 was induced in primary PMCs by uPA and plasmin and induced markers of MesoMT. Conclusion: To our knowledge, this is the first murine model of subacute, organizing empyema. The model can be used to identify factors that, like PAI-1 deficiency, alter outcomes and dissect their contribution to pleural organization, rind formation and lung restriction.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 DEFICIENCY
    FAY, WP
    SHAPIRO, AD
    SHIH, JL
    SCHLEEF, RR
    GINSBURG, D
    CIRCULATION, 1992, 86 (04) : S12 - S12
  • [2] Plasminogen activator inhibitor-1
    Gils, A
    Declerck, PJ
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (17) : 2323 - 2334
  • [3] Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice
    Mizukami, Yuya
    Kawao, Naoyuki
    Ohira, Takashi
    Okada, Kiyotaka
    Yamao, Hisatoshi
    Matsuo, Osamu
    Kaji, Hiroshi
    PLOS ONE, 2024, 19 (10):
  • [4] Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy
    Nicholas, SB
    Aguiniga, E
    Ren, YL
    Kim, J
    Wong, J
    Govindarajan, N
    Noda, M
    Wang, W
    Kawano, Y
    Collins, A
    Hsueh, WA
    KIDNEY INTERNATIONAL, 2005, 67 (04) : 1297 - 1307
  • [5] Analysis of a large pedigree with plasminogen activator inhibitor-1 deficiency
    Fay, WP
    Shapiro, AD
    CIRCULATION, 1996, 94 (08) : 2689 - 2689
  • [6] Plasminogen activator inhibitor-1 deficiency prevents hypertension and arteriosclerosis
    Kaikita, K
    Fogo, AB
    Ma, L
    Schoenhard, JA
    Brown, NJ
    Vaughan, DE
    CIRCULATION, 2000, 102 (18) : 80 - 81
  • [7] Fracture Healing in Mice Deficient in Plasminogen Activator Inhibitor-1
    Rundle, Charles H.
    Wang, Xiaoguang
    Wergedal, Jon E.
    Mohan, Subburaman
    Lau, K. -H. William
    CALCIFIED TISSUE INTERNATIONAL, 2008, 83 (04) : 276 - 284
  • [8] Fracture Healing in Mice Deficient in Plasminogen Activator Inhibitor-1
    Charles H. Rundle
    Xiaoguang Wang
    Jon E. Wergedal
    Subburaman Mohan
    K.-H. William Lau
    Calcified Tissue International, 2008, 83 : 276 - 284
  • [9] Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice
    Farrehi, PM
    Ozaki, CK
    Carmeliet, P
    Fay, WP
    CIRCULATION, 1998, 97 (10) : 1002 - 1008
  • [10] Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice
    Akihiro Moritake
    Naoyuki Kawao
    Kiyotaka Okada
    Kohei Tatsumi
    Masayoshi Ishida
    Katsumi Okumoto
    Osamu Matsuo
    Masao Akagi
    Hiroshi Kaji
    BMC Musculoskeletal Disorders, 18